07.07.2017 • NewsElaine BurridgeNovacapEurazeo

Eurazeo Takes Majority Stake in Iberchem

(c) https://www.facebook.com/Iberchem/photos
(c) https://www.facebook.com/Iberchem/photos

French investment group Eurazeo has paid around €270 million to gain a 70% stake in Spanish flavors and fragrances company Iberchem. The deal, which represents an enterprise value of €405 million, is set to close later in July.

Headquartered in Murcia, Iberchem sells in more than 100 countries and operates 11 manufacturing facilities worldwide, including in Spain, China, Indonesia, Colombia and Tunisia. The company serves the hygiene and personal care industry through its fragrances division and the food and beverage industry through its flavors business, Scentium.

With the investment, Eurazeo said it will support Iberchem’s management team in the next phase of the company’s development. Iberchem has seen double-digit organic growth since its creation in 1985 by current CEO, Ramon Fernandez, and annual sales have grown by 18% from 2012 to 2016. “Iberchem will be able to continue on its successful path and increase its leadership through organic growth in existing and new markets and selective M&A,” Fernandez said.

Eurazeo’s deputy CEO, Virginie Morgon, noted that Iberchem meets all the required investment criteria, in particular a strong management team driving superior organic growth with an agile business model that is benefiting from a rising middle class in emerging markets. “We will leverage our expertise in Iberchem's underlying markets, as well as our international network, to accelerate the growth of the company,” she said.

The Paris-headquartered investment firm has also held a majority stake in French chemicals company Novacap since 2016.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.